Pear therapeutics logo
WebMar 17, 2024 · Pear’s stock closed at 39 cents a share on Friday, down 34% from 59 cents at yesterday’s close. The Boston-based company had raised $250 million in venture funding from investors including ...
Pear therapeutics logo
Did you know?
WebApr 3, 2024 · Pear Therapeutics has an analyst consensus of Hold, with a price target consensus of $3.67, representing a 1,339.22% upside. In a report released on March 20, … WebMar 17, 2024 · Pear Therapeutics, which has three FDA-cleared prescription apps to help treat substance use disorder and insomnia, announced Friday it was “exploring strategic …
WebBusiness Insider Intelligence. Swiss drug maker Novartis' Sandoz ended its partnership with Pear Therapeutics, which started in 2024 and was aimed at helping Pear market its FDA … WebApr 14, 2024 · Among that is what has shares of Pear Therapeutics (NASDAQ: PEAR ), Petros Pharmaceuticals (NASDAQ: PTPI ), CXApp (NASDAQ: CXAI) stock moving today. You can find out all of this news at the...
WebCompany - Public ( PEAR) Industry: Biotech & Pharmaceuticals. Revenue: $1 to $5 million (USD) Competitors: Unknown. Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients ... WebNov 15, 2024 · Pear Therapeutics, a Boston-based maker of app-based programs that are prescribed to treat insomnia and substance use disorder, will cut 22% of its staff in a bid to reduce costs amid a “ challenging macroeconomic environment.” The layoffs, affecting about 59 employees, are intended to extend Pear’s “cash runway” and reduce its reliance …
WebMar 17, 2024 · BOSTON--(BUSINESS WIRE)--Mar. 17, 2024-- Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software …
WebOct 16, 2024 · Editor's Note: This story has been updated with additional quotes from Pear Therapeutics. The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division Sandoz announced that it is handing sole responsibility for the commercialization of the reSET and reSET-O prescription digital therapeutics back to … halloween costumes jokerWebPear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics … halloween costumes skin suitWebApr 7, 2024 · April 7, 2024 at 11:53 a.m. ET. By Colin Kellaher. Pear Therapeutics Inc. on Friday said it has filed for chapter 11 bankruptcy with plans to sell its assets through a … halloween eimer kikWebBusiness Insider Intelligence. Swiss drug maker Novartis' Sandoz ended its partnership with Pear Therapeutics, which started in 2024 and was aimed at helping Pear market its FDA-approved digital ... halloween costumi 12 mesiWebPear Therapeutics is registered under the ticker NASDAQ:PEAR . Stock Symbol NASDAQ:PEAR Valuation at IPO $1.6B Money Raised at IPO $400M IPO Date Dec 3, 2024 Stock chart by Investors Number of Lead Investors 6 Number of Investors 23 Pear Therapeutics is funded by 23 investors. halloween costumes yukon okWebJun 23, 2024 · Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based ... halloween dad jokes 2020WebPear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software … halloween dental jokes